Because we know the massive revenue potential......telehealth provider in Europe has always been the key as they are well advanced compare to others and will make their competitor sign up and then "force" the doctors in clinic to use the technology or they will loss out of respiratory consultation.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp appoints VP, Commercial to progress growth strategy
Ann: ResApp appoints VP, Commercial to progress growth strategy, page-153
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)